Global Gene Therapy For Parkinson’s Disease Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Gene Therapy For Parkinson’s Disease Global Market Report 2025

Name: Gene Therapy For Parkinson’s Disease Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Therapy Type (In Vivo Gene Therapy, Ex Vivo Gene Therapy); By Vector Type (Viral Vectors, Non-Viral Vectors); By Target Gene (Aromatic L-Amino Acid Decarboxylase (AADC), Glial Cell Line-Derived Neurotrophic Factor (GDNF), Neurturin, Other Target Genes); By Delivery Method (Intracerebral, Intravenous, Other Delivery Methods); By End-User (Hospitals, Specialty Clinics, Research Institutes, Other End-Users); Subsegments:; By In Vivo Gene Therapy (Viral Vectors, Non-Viral Vectors); By Ex Vivo Gene Therapy (Autologous Cell-Based Gene Therapy, Allogeneic Cell-Based Gene Therapy) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gene Therapy For Parkinson’s Disease Market Overview

• Gene Therapy For Parkinson’s Disease market size has reached to $0.51 billion in 2024

• Expected to grow to $1.62 billion in 2029 at a compound annual growth rate (CAGR) of 26.1%

• Growth Driver: Growing Interest In Personalized Medicine Driving The Growth Of The Market Due To Rising Demand For Targeted And Effective Treatments

• Market Trend: Accelerating Development Of Innovative Gene Therapies

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gene Therapy For Parkinson’s Disease Market?

Gene Therapy for Parkinson’s disease refers to the use of genetic techniques to introduce, repair, or regulate genes within brain cells. It is designed to restore dopamine production, protect nerve cells, or correct disease-related mutations. The approach aims to slow disease progression and provide sustained symptom relief.

The main therapy types of gene therapy for parkinson’s disease are in vivo gene therapy and ex vivo gene therapy. In vivo gene therapy refers to the direct delivery of genetic material into the patient’s body, typically using viral or non-viral vectors, to restore or enhance the function of specific genes involved in Parkinson’s disease progression. These therapies target genes such as aromatic L-amino acid decarboxylase (AADC), glial cell line-derived neurotrophic factor (GDNF), neurturin, and other related genes, and are administered through delivery methods including intracerebral, intravenous, and other approaches. The key end-users include hospitals, specialty clinics, research institutes, and others.

Gene Therapy For Parkinson’s Disease Market Size and growth rate 2025 to 2029: Graph

What Is The Gene Therapy For Parkinson’s Disease Market Size 2025 And Growth Rate?

What Is The Gene Therapy For Parkinson’s Disease Market Growth Forecast?

The gene therapy for parkinson’s disease market size is expected to see exponential growth in the next few years. It will grow to $1.62 billion in 2029 at a compound annual growth rate (CAGR) of 26.1%. The growth in the forecast period can be attributed to growing adoption of viral vector-based therapies, increasing investments in gene therapy startups, rising government support for rare disease treatments, expansion of research collaborations, and growing healthcare infrastructure in emerging markets. Major trends in the forecast period include technological advancements in viral delivery systems, innovations in neurotrophic factor therapies, development of targeted gene-editing constructs, increasing research and development investments, and advancements in precision medicine approaches.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How the Gene Therapy For Parkinson’s Disease Market Segmented?

1) By Therapy Type: In Vivo Gene Therapy, Ex Vivo Gene Therapy

2) By Vector Type: Viral Vectors, Non-Viral Vectors

3) By Target Gene: Aromatic L-Amino Acid Decarboxylase (AADC), Glial Cell Line-Derived Neurotrophic Factor (GDNF), Neurturin, Other Target Genes

4) By Delivery Method: Intracerebral, Intravenous, Other Delivery Methods

5) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegment:

1) By In Vivo Gene Therapy: Viral Vectors, Non-Viral Vectors

2) By Ex Vivo Gene Therapy: Autologous Cell-Based Gene Therapy, Allogeneic Cell-Based Gene Therapy

What Is Driving The Gene Therapy For Parkinson’s Disease Market? Growing Interest In Personalized Medicine Driving The Growth Of The Market Due To Rising Demand For Targeted And Effective Treatments

The growing interest in personalized medicine is expected to propel the growth of the gene therapy for Parkinson’s disease market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to an individual's genetic makeup, lifestyle, and environment. Interest in personalized medicine is rising due to the growing demand for targeted therapies that improve treatment effectiveness while minimizing adverse side effects. Gene therapy for Parkinson’s disease in personalized medicine is used to deliver tailored genetic modifications that restore dopamine function and address individual patient-specific disease mechanisms. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the US Food and Drug Administration (FDA) granted approval for 16 new personalized treatments for rare disease patients, marking a substantial increase from the 6 approvals in 2022. Therefore, the growing interest in personalized medicine is driving the growth of gene therapy for Parkinson’s disease industry.

Who Are The Major Players In The Global Gene Therapy For Parkinson’s Disease Market?

Major companies operating in the gene therapy for parkinson’s disease market are Merck & Co. Inc., Bayer AG, Sanofi S.A., Eli Lilly and Company, Biogen Inc., PTC Therapeutics Inc., Zambon S.p.A., Oxford BioMedica plc, Voyager Therapeutics Inc., Insilico Medicine Inc., Spur Therapeutics Inc., Cerevance Inc., MeiraGTx Holdings plc, BlackfinBio Inc., Partner Therapeutics Inc., Kenai Therapeutics Inc., CureSen Therapeutics Inc., BioVie Inc., Clexio Biosciences Ltd., Tetraneuron S.L.

What Are The Key Trends Of The Global Gene Therapy For Parkinson’s Disease Market? Accelerating Development Of Innovative Gene Therapies

Major companies are operating in the gene therapy for Parkinson’s disease market, focusing on developing more precise therapy, such as regenerative medicine advanced therapy, to enhance neuronal survival, restore dopamine function, and provide long-lasting disease-modifying benefits for patients with Parkinson’s disease. Regenerative medicine advanced therapy (RMAT) refers to a special United States Food and Drug Administration (FDA) designation granted to regenerative medicine products, such as cell therapies, gene therapies, and tissue-engineered products, that are intended to treat, modify, reverse, or cure serious or life-threatening diseases. For instance, in February 2025, Asklepios BioPharmaceutical, Inc. (AskBio), a US-based gene therapy company, introduced AB-1005, an investigational AAV2-GDNF gene therapy that received FDA regenerative medicine advanced therapy (RMAT) designation. The designation, which is intended to expedite the development and review of promising therapies, was granted based on data submitted by AskBio, including clinical evidence from its Phase Ib open-label, uncontrolled trial, demonstrating AB-1005’s potential to slow disease progression and improve motor function in Parkinson’s patients.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Gene Therapy For Parkinson’s Disease Market? Roche Expands Capabilities With Poseida Acquisition

In January 2025, BlackfinBio Limited, a UK-based provider of clinical-stage gene therapy solutions for rare neurological and dopamine-deficiency disorders, acquired the Parkinson’s patent portfolio from Oxford Biomedica plc for an undisclosed amount. Through this acquisition, BlackfinBio aims to advance its BFB-201 program targeting Parkinson’s disease and leverage Oxford Biomedica’s expertise in gene and cell therapy IP to accelerate therapeutic development. Oxford Biomedica plc is a UK-based provider of gene and cell therapy development and vector technologies, bringing valuable intellectual property that complements.

What Is The Regional Outlook For The Global Gene Therapy For Parkinson’s Disease Market?

North America was the largest region in the gene therapy for parkinson’s disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gene Therapy For Parkinson’s Disease Market?

The gene therapy for parkinson’s disease market consists of revenues earned by entities by providing services such as genetic counseling, preclinical studies, clinical trial management, and personalized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene therapy for parkinson’s disease market also includes sales of viral vectors, aromatic L-amino acid decarboxylase (AADC) gene therapy, glutamic acid decarboxylase (GAD) gene therapy, glial cell line-derived neurotrophic factor (GDNF) or neurturin-based neurotrophic therapies, and glucocerebrosidase (GBA)-targeted gene therapies. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Gene Therapy For Parkinson’s Disease Industry?

The gene therapy for parkinson’s disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gene therapy for parkinson’s disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

1. Executive Summary

2. Gene Therapy For Parkinson’s Disease Market Characteristics

3. Gene Therapy For Parkinson’s Disease Market Trends And Strategies

4. Gene Therapy For Parkinson’s Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gene Therapy For Parkinson’s Disease Growth Analysis And Strategic Analysis Framework

5.1. Global Gene Therapy For Parkinson’s Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Gene Therapy For Parkinson’s Disease Market Growth Rate Analysis

5.4. Global Gene Therapy For Parkinson’s Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Gene Therapy For Parkinson’s Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Gene Therapy For Parkinson’s Disease Total Addressable Market (TAM)

6. Gene Therapy For Parkinson’s Disease Market Segmentation

6.1. Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

In Vivo Gene Therapy

Ex Vivo Gene Therapy

6.2. Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral Vectors

Non-Viral Vectors

6.3. Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Aromatic L-Amino Acid Decarboxylase (AADC)

Glial Cell Line-Derived Neurotrophic Factor (GDNF)

Neurturin

Other Target Genes

6.4. Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intracerebral

Intravenous

Other Delivery Methods

6.5. Global Gene Therapy For Parkinson’s Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Research Institutes

Other End-Users

6.6. Global Gene Therapy For Parkinson’s Disease Market, Sub-Segmentation Of In Vivo Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral Vectors

Non-Viral Vectors

6.7. Global Gene Therapy For Parkinson’s Disease Market, Sub-Segmentation Of Ex Vivo Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Autologous Cell-Based Gene Therapy

Allogeneic Cell-Based Gene Therapy

7. Gene Therapy For Parkinson’s Disease Market Regional And Country Analysis

7.1. Global Gene Therapy For Parkinson’s Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Gene Therapy For Parkinson’s Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Therapy For Parkinson’s Disease Market

8.1. Asia-Pacific Gene Therapy For Parkinson’s Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Therapy For Parkinson’s Disease Market

9.1. China Gene Therapy For Parkinson’s Disease Market Overview

9.2. China Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Therapy For Parkinson’s Disease Market

10.1. India Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Therapy For Parkinson’s Disease Market

11.1. Japan Gene Therapy For Parkinson’s Disease Market Overview

11.2. Japan Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Therapy For Parkinson’s Disease Market

12.1. Australia Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Therapy For Parkinson’s Disease Market

13.1. Indonesia Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Therapy For Parkinson’s Disease Market

14.1. South Korea Gene Therapy For Parkinson’s Disease Market Overview

14.2. South Korea Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Therapy For Parkinson’s Disease Market

15.1. Western Europe Gene Therapy For Parkinson’s Disease Market Overview

15.2. Western Europe Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Therapy For Parkinson’s Disease Market

16.1. UK Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Therapy For Parkinson’s Disease Market

17.1. Germany Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Therapy For Parkinson’s Disease Market

18.1. France Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Therapy For Parkinson’s Disease Market

19.1. Italy Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Therapy For Parkinson’s Disease Market

20.1. Spain Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Therapy For Parkinson’s Disease Market

21.1. Eastern Europe Gene Therapy For Parkinson’s Disease Market Overview

21.2. Eastern Europe Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Therapy For Parkinson’s Disease Market

22.1. Russia Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Therapy For Parkinson’s Disease Market

23.1. North America Gene Therapy For Parkinson’s Disease Market Overview

23.2. North America Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Therapy For Parkinson’s Disease Market

24.1. USA Gene Therapy For Parkinson’s Disease Market Overview

24.2. USA Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Therapy For Parkinson’s Disease Market

25.1. Canada Gene Therapy For Parkinson’s Disease Market Overview

25.2. Canada Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Therapy For Parkinson’s Disease Market

26.1. South America Gene Therapy For Parkinson’s Disease Market Overview

26.2. South America Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Therapy For Parkinson’s Disease Market

27.1. Brazil Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Therapy For Parkinson’s Disease Market

28.1. Middle East Gene Therapy For Parkinson’s Disease Market Overview

28.2. Middle East Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Therapy For Parkinson’s Disease Market

29.1. Africa Gene Therapy For Parkinson’s Disease Market Overview

29.2. Africa Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Therapy For Parkinson’s Disease Market Competitive Landscape And Company Profiles

30.1. Gene Therapy For Parkinson’s Disease Market Competitive Landscape

30.2. Gene Therapy For Parkinson’s Disease Market Company Profiles

30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Gene Therapy For Parkinson’s Disease Market Other Major And Innovative Companies

31.1. PTC Therapeutics Inc.

31.2. Zambon S.p.A.

31.3. Oxford BioMedica plc

31.4. Voyager Therapeutics Inc.

31.5. Insilico Medicine Inc.

31.6. Spur Therapeutics Inc.

31.7. Cerevance Inc.

31.8. MeiraGTx Holdings plc

31.9. BlackfinBio Inc.

31.10. Partner Therapeutics Inc.

31.11. Kenai Therapeutics Inc.

31.12. CureSen Therapeutics Inc.

31.13. BioVie Inc.

31.14. Clexio Biosciences Ltd.

31.15. Tetraneuron S.L.

32. Global Gene Therapy For Parkinson’s Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Therapy For Parkinson’s Disease Market

34. Recent Developments In The Gene Therapy For Parkinson’s Disease Market

35. Gene Therapy For Parkinson’s Disease Market High Potential Countries, Segments and Strategies

35.1 Gene Therapy For Parkinson’s Disease Market In 2029 - Countries Offering Most New Opportunities

35.2 Gene Therapy For Parkinson’s Disease Market In 2029 - Segments Offering Most New Opportunities

35.3 Gene Therapy For Parkinson’s Disease Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Gene Therapy For Parkinson’s Disease Market, Sub-Segmentation Of In Vivo Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Gene Therapy For Parkinson’s Disease Market, Sub-Segmentation Of Ex Vivo Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Gene Therapy For Parkinson’s Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Gene Therapy For Parkinson’s Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Merck & Co. Inc. Financial Performance

Table 79: Bayer AG Financial Performance

Table 80: Sanofi S.A. Financial Performance

Table 81: Eli Lilly and Company Financial Performance

Table 82: Biogen Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Gene Therapy For Parkinson’s Disease Market, Sub-Segmentation Of In Vivo Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Gene Therapy For Parkinson’s Disease Market, Sub-Segmentation Of Ex Vivo Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Gene Therapy For Parkinson’s Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Gene Therapy For Parkinson’s Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Merck & Co. Inc. Financial Performance

Figure 79: Bayer AG Financial Performance

Figure 80: Sanofi S.A. Financial Performance

Figure 81: Eli Lilly and Company Financial Performance

Figure 82: Biogen Inc. Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Neurological Disorder Drugs Global Market Report 2025 – By Drug Class (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor Antagonists, Antiepileptic, Antipsychotic And Antidepressant, Other Drugs Classes), B...

Gene Therapy Global Market Report 2025 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurologi...

Anti-Parkinson Drugs Global Market Report 2025 – By Drugs Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergi...

Nucleic Acid Based Gene Therapy Global Market Report 2025 – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By App...

Cell And Gene Therapy Clinical Trial Services Global Market Report 2025 – By Service (Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, S...

Gene Editing Global Market Report 2025 – By Technology (CRISPR, TALEN, ZFN), By Application (Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering), By End Users (Biotechnology, Pharmaceutical, Con...

Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2025 – By Type Of Software Solution (Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Man...

Frequently Asked Questions

What is the definition of the Gene Therapy For Parkinson’s Disease market?

Gene therapy for Parkinson’s disease refers to the use of genetic techniques to introduce, repair, or regulate genes within brain cells. It is designed to restore dopamine production, protect nerve cells, or correct disease-related mutations. The approach aims to slow disease progression and provide sustained symptom relief. For further insights on this market, request a sample here

How will the Gene Therapy For Parkinson’s Disease market drivers and restraints affect the market dynamics? What forces will shape the Gene Therapy For Parkinson’s Disease industry going forward?

The market major growth driver - Growing Interest In Personalized Medicine Driving The Growth Of The Market Due To Rising Demand For Targeted And Effective Treatments. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Gene Therapy For Parkinson’s Disease market?

The gene therapy for parkinson’s disease market size has grown exponentially in recent years. It will grow from $0.51 billion in 2024 to $0.64 billion in 2025 at a compound annual growth rate (CAGR) of 26.5%. The growth in the historic period can be attributed to increasing prevalence of parkinson’s disease, rising demand for personalized therapies, growing awareness about gene therapy, expansion of clinical trial networks, and increasing funding for neurodegenerative research. The gene therapy for parkinson’s disease market size is expected to see exponential growth in the next few years. It will grow to $1.62 billion in 2029 at a compound annual growth rate (CAGR) of 26.1%. The growth in the forecast period can be attributed to growing adoption of viral vector-based therapies, increasing investments in gene therapy startups, rising government support for rare disease treatments, expansion of research collaborations, and growing healthcare infrastructure in emerging markets. Major trends in the forecast period include technological advancements in viral delivery systems, innovations in neurotrophic factor therapies, development of targeted gene-editing constructs, increasing research and development investments, and advancements in precision medicine approaches. For further insights on this market, request a sample here

How is the Gene Therapy For Parkinson’s Disease market segmented?

The gene therapy for parkinson’s disease market covered in this report is segmented as
1) By Therapy Type: In Vivo Gene Therapy, Ex Vivo Gene Therapy
2) By Vector Type: Viral Vectors, Non-Viral Vectors
3) By Target Gene: Aromatic L-Amino Acid Decarboxylase (AADC), Glial Cell Line-Derived Neurotrophic Factor (GDNF), Neurturin, Other Target Genes
4) By Delivery Method: Intracerebral, Intravenous, Other Delivery Methods
5) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users Subsegment:
1) By In Vivo Gene Therapy: Viral Vectors, Non-Viral Vectors
2) By Ex Vivo Gene Therapy: Autologous Cell-Based Gene Therapy, Allogeneic Cell-Based Gene Therapy For further insights on this market, request a sample here

Which region has the largest share of the Gene Therapy For Parkinson’s Disease market? What are the other regions covered in the report?

North America was the largest region in the gene therapy for parkinson’s disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gene therapy for parkinson’s disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Who are the major players in the Gene Therapy For Parkinson’s Disease market?

What are the key trends in the Gene Therapy For Parkinson’s Disease market?

Major trends in this market include Accelerating Development Of Innovative Gene Therapies For further insights on this market, request a sample here.